|
1
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peng L: Progress in the treatment of
osteosarcoma. Int J Orthop. 29:91–93. 2008.
|
|
3
|
Qiu Z and Liao Q: Progress of osteosarcoma
therapy. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 24:1469–1475.
2010.(In Chinese). PubMed/NCBI
|
|
4
|
Jones-Rhoades MW and Bartel DP:
Computational identification of plant micrornas and their targets,
including a stress-induced miRNA. Mol Cell. 14:787–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zalfa F, Giorgi M, Primerano B, Moro A, Di
Penta A, Reis S, Oostra B and Bagni C: The fragile X syndrome
protein FMRP associates with BC1 RNA and Regulates the translation
of specific mRNAat synapses. Cell. 112:317–327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Liu L, Xu Q, Wu P, Zuo X and Ji A:
MicroRNA as a novel drug target for cancer therapy. Expert Opin
Biol Ther. 12:573–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou F, Li Y, Hao Z, Liu X, Chen L, Cao Y,
Liang Z, Yuan F, Liu J, Wang J, et al: MicroRNA-300 inhibited
glioblastoma progression through ROCK1. Oncotarget. 7:36529–36538.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nairismägi ML, Füchtbauer A, Labouriau R,
Bramsen JB and Füchtbauer EM: The proto-oncogene TWIST1 is
regulated by microRNAs. PLos One. 8:e660702013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sánchez-Tilló E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho WH, Lee HJ, Choi YJ, Oh JH, Kim HS and
Cho HS: Capsaicin induces apoptosis in MG63 human osteosarcoma
cells via the caspase cascade and the antioxidant enzyme system.
Mol Med Rep. 8:1655–1662. 2013.PubMed/NCBI
|
|
13
|
Zhang N, Su Y and Xu L: Targeting PKCε by
miR-143 regulates cell apoptosis in lung cancer. FEBS Lett.
587:3661–3667. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi W, Bruce J, Lee M, Yue S, Rowe M,
Pintilie M, Kogo R, Bissey PA, Fyles A, Yip KW and Liu FF: MiR-449a
promotes breast cancer progression by targeting CRIP2. Oncotarget.
7:18906–18918. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rojas RE, Balaji KN, Subramanian A and
Boom WH: Regulation of human CD4(+) alphabeta
T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell
responses to Mycobacterium tuberculosis by interleukin-10 and
transforming growth factor beta. Infect Immun. 67:6461–6472.
1999.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin SS, Keshavjee S, Gelmanova IY, Atwood
S, Franke MF, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD,
Barnashov A, et al: Development of extensively drug-resistant
tuberculosis during multidrug-resistant tuberculosis treatment. Am
J Respir Crit Care Med. 182:426–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang GC, He QY, Tong DK, Wang CF, Liu K,
Ding C, Ji F and Zhang H: MiR-367 negatively regulates apoptosis
induced by adriamycin in osteosarcoma cells by targeting KLF4. J
Bone Oncol. 5:51–56. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin BC, Huang D, Yu CQ, Mou Y, Liu YH,
Zhang DW and Shi FJ: MicroRNA-184 modulates doxorubicin resistance
in osteosarcoma cells by targeting BCL2L1. Med Sci Monit.
22:1761–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Geng S, Gu L, Ju F, Zhang H, Wang Y, Tang
H, Bi Z and Yang C: MicroRNA-224 promotes the sensitivity of
osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med.
20:1611–1619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu F, Gao J, Zhang Z, Ge J, Wei Z and
Cheng W: Expression of miRNA-300 in urothelial carcinoma of the
bladder. J Medical Res. 2012.
|
|
25
|
Lin W: A preliminary study of miRNA-300
regulation in invasion and proliferation of colorectal cancer
(unpublished PhD thesis). Third Military Medical University.
2015.(In Chinese).
|
|
26
|
Karbasy SH, Taheriazam A, Mirghasemi A,
Sedaghati F, Shakeri M, Yahaghi E and Bahador R: RETRACTED ARTICLE:
Upregulation of miR-300 and downregulation of miR-125b act as
potential predictor biomarkers in progression, metastasis, and poor
prognosis of osteosarcoma. Tumor Biol. 2015.(Epub ahead of
print).
|
|
27
|
Xue Z, Zhao J, Niu L, An G, Guo Y and Ni
L: Up-regulation of MiR-300 promotes proliferation and invasion of
osteosarcoma by targeting BRD7. PLoS One. 10:e01276822015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Banzhaf-Strathmann J and Edbauer D: Good
guy or bad guy: The opposing roles of microRNA 125b in cancer. Cell
Commun Signal. 12:302014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maestro R, Dei Tos AP, Hamamori Y,
Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH and
Hannon GJ: Twist is a potential oncogene that inhibits apoptosis.
Genes Dev. 13:2207–2217. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou
X, Zhang ZJ, Peng YH, Yang YZ and Yun JP: miR-720 inhibits tumor
invasion and migration in breast cancer by targeting TWIST1.
Carcinogenesis. 35:469–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nairismägi ML, Füchtbauer A, Labouriau R,
Bramsen JB and Füchtbauer EM: The protooncogene TWIST1 is regulated
by microRNAs. PLoS One. 8:e660702013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong P, Kaneuchi M, Watari H, Sudo S and
Sakuragi N: MicroRNA-106b modulates epithelial-mesenchymal
transition by targeting TWIST1 in invasive endometrial cancer cell
lines. Mol Carcinog. 53:349–359. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou Y, Zang X, Huang Z and Zhang C: TWIST
interacts with endothelin-1/endothelin A receptor signaling in
osteosarcoma cell survival against cisplatin. Oncol Lett.
5:857–861. 2013.PubMed/NCBI
|
|
34
|
Wu J, Liao Q, He H, Da Z and Ke Y: TWIST
interacts with β-catenin signaling on osteosarcoma cell survival
against cisplatin. Mol Carcinog. 53:440–446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu G, Shen J, Yu A, Wang H, Man TK and Lau
CC: Abstract 3402: Knockdown of TWIST1 increases chemosensitivity
of osteosarcoma cells. Cancer Res. 70:34022010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wullaert A, Verstrepen L, Van Huffel S,
Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K,
Sanders M, Verhelst K, et al: LIND/ABIN-3 is a novel
lipopolysaccharide-inducible inhibitor of NF-kappaB activation. J
Biol Chem. 282:81–90. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao Y, Li Z, Wang W, Zhang H, Chen J, Su
P, Liu L and Li W: Naringin protects against cartilage destruction
in osteoarthritis through repression of NF-κB signaling pathway.
Inflammation. 39:385–392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Horikawa T, Yang J, Kondo S, Yoshizaki T,
Joab I, Furukawa M and Pagano JS: Twist and epithelial-mesenchymal
transition are induced by the EBV oncoprotein latent membrane
protein 1 and are associated with metastatic nasopharyngeal
carcinoma. Cancer Res. 67:1970–1983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lv N, Shan Z, Gao Y, Guan H, Fan C, Wang H
and Teng W: Twist1 regulates the epithelial-mesenchymal transition
via the NF-κB pathway in papillary thyroid carcinoma. Endocrine.
51:469–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sethi G, Ahn KS and Aggarwal BB: Targeting
nuclear factor-kappa B activation pathway by thymoquinone: Role in
suppression of antiapoptotic gene products and enhancement of
apoptosis. Mol Cancer Res. 6:1059–1070. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brandwood CP, Hoyland JA, Hillarby MC,
Berry JL, Davies M, Selby PL and Mee AP: Apoptotic gene expression
in Paget's disease: A possible role for Bcl-2. J Pathol.
201:504–512. 2003. View Article : Google Scholar : PubMed/NCBI
|
